(Q33982095)

English

A comparison of multidrug-resistant tuberculosis treatment commencement times in MDRTBPlus line probe assay and Xpert® MTB/RIF-based algorithms in a routine operational setting in Cape Town

scientific article published on 31 July 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 July 2017

A comparison of multidrug-resistant tuberculosis treatment commencement times in MDRTBPlus line probe assay and Xpert® MTB/RIF-based algorithms in a routine operational setting in Cape Town (English)

1 reference

Europe PubMed Central

30 July 2017

0 references

0 references

multiple drug resistance

1 reference

based on heuristic

inferred from title

0 references

multidrug-resistant tuberculosis

1 reference

based on heuristic

inferred from title

object named as

S Bertel Squire

7

0 references

9

object named as

Nulda Beyers

1 reference

Europe PubMed Central

30 July 2017

Donald A. Enarson

8

object named as

Donald A Enarson

1 reference

Europe PubMed Central

30 July 2017

author name string

Pren Naidoo

1

1 reference

Europe PubMed Central

30 July 2017

Elizabeth du Toit

2

1 reference

Europe PubMed Central

30 July 2017

Rory Dunbar

3

1 reference

Europe PubMed Central

30 July 2017

Carl Lombard

4

1 reference

Europe PubMed Central

30 July 2017

Judy Caldwell

5

1 reference

Europe PubMed Central

30 July 2017

Anne Detjen

6

1 reference

Europe PubMed Central

30 July 2017

language of work or name

0 references

publication date

31 July 2014

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

9

1 reference

Europe PubMed Central

30 July 2017

7

1 reference

Europe PubMed Central

30 July 2017

e103328

1 reference

Europe PubMed Central

30 July 2017

copyright license

Creative Commons Attribution 4.0 International

31 July 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

describes a project that uses

1 reference

Europe PubMed Central

26 June 2022

https://europepmc.org/article/PMC/PMC4117508

based on heuristic

inferred from PubMed Central ID database lookup

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4117508

5 July 2018

Low treatment initiation rates among multidrug-resistant tuberculosis patients in Gauteng, South Africa, 2011.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4117508

5 July 2018

Time to treatment and patient outcomes among TB suspects screened by a single point-of-care xpert MTB/RIF at a primary care clinic in Johannesburg, South Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4117508

5 July 2018

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4117508

5 July 2018

Implementation of genotype MTBDRplus reduces time to multidrug-resistant tuberculosis therapy initiation in South Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4117508

5 July 2018

The impact and cost of scaling up GeneXpert MTB/RIF in South Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4117508

5 July 2018

Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4117508

5 July 2018

Beyond accuracy: creating a comprehensive evidence base for TB diagnostic tools

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4117508

5 July 2018

MDR tuberculosis--critical steps for prevention and control

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4117508

5 July 2018

Rapid molecular detection of tuberculosis and rifampin resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4117508

5 July 2018

New and improved tuberculosis diagnostics: evidence, policy, practice, and impact

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4117508

5 July 2018

Novel and improved technologies for tuberculosis diagnosis: progress and challenges

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4117508

5 July 2018

Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4117508

5 July 2018

GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4117508

5 July 2018

Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4117508

5 July 2018

Detecting drug-resistant tuberculosis: the importance of rapid testing.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103328

21 January 2018

Genotype MTBDRplus: a further step toward rapid identification of drug-resistant Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103328

21 January 2018

Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB/RIF assay: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0103328

21 January 2018

Delay in commencing treatment for MDR TB at a specialised TB treatment centre in KwaZulu-Natal

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4117508

29 October 2018

Timely diagnosis of MDR-TB under program conditions: is rapid drug susceptibility testing sufficient?

1 reference

https://pubmed.ncbi.nlm.nih.gov/25079599

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Application of the Genotype MTBDR assay directly on sputum specimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/25079599

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0103328

1 reference

Europe PubMed Central

30 July 2017

2014PLoSO...9j3328N

0 references

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33982095&oldid=1861016290"